$AUXL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AUXILIUM PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AUXILIUM PHARMACEUTICALS INC. Get notifications about new insider transactions in AUXILIUM PHARMACEUTICALS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 26 2005 | AUXL | AUXILIUM PHARMACEU ... | HENWOOD GERALDINE | Chief Executive Off ... | Gift | G | 0.00 | 37,960 | 0 | 255,840 | 293.8 K to 255.8 K (-12.92 %) |
Aug 26 2005 | AUXL | AUXILIUM PHARMACEU ... | Bescherer Edwin A Jr | Director | Option Exercise | A | 4.15 | 10,000 | 41,500 | 10,000 | |
Aug 11 2005 | AUXL | AUXILIUM PHARMACEU ... | CHAMBON PHILIPPE | Director | Option Exercise | A | 4.15 | 10,000 | 41,500 | 10,000 | |
Aug 10 2005 | AUXL | AUXILIUM PHARMACEU ... | CHURCHILL WINSTON J | Director | Option Exercise | A | 4.15 | 10,000 | 41,500 | 10,000 | |
Aug 09 2005 | AUXL | AUXILIUM PHARMACEU ... | Purcell Dennis J | Director | Option Exercise | A | 4.15 | 10,000 | 41,500 | 10,000 | |
Aug 09 2005 | AUXL | AUXILIUM PHARMACEU ... | SOROS FUND MANAGEMENT LLC | 10% Owner | Option Exercise | J | 4.15 | 10,000 | 41,500 | 10,000 | |
Aug 09 2005 | AUXL | AUXILIUM PHARMACEU ... | PEARL FRANK H | 10% Owner | Option Exercise | J | 4.15 | 10,000 | 41,500 | 10,000 | |
Aug 08 2005 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Option Exercise | A | 4.15 | 10,000 | 41,500 | 10,000 | |
Jul 05 2005 | AUXL | AUXILIUM PHARMACEU ... | SCP PRIVATE EQUITY PARTNERS II ... | 10% Owner | Option Exercise | P | 5.84 | 165,234 | 964,967 | 165,234 | |
Jul 05 2005 | AUXL | AUXILIUM PHARMACEU ... | SCP PRIVATE EQUITY PARTNERS II ... | 10% Owner | Buy | P | 4.90 | 661,056 | 3,239,174 | 3,687,878 | 3 M to 3.7 M (+21.84 %) |
Jul 05 2005 | AUXL | AUXILIUM PHARMACEU ... | CHURCHILL WINSTON J | Director | Option Exercise | P | 5.84 | 71,410 | 417,034 | 71,410 | |
Jul 05 2005 | AUXL | AUXILIUM PHARMACEU ... | CHURCHILL WINSTON J | Director | Option Exercise | P | 5.84 | 165,234 | 964,967 | 165,234 | |
Jul 05 2005 | AUXL | AUXILIUM PHARMACEU ... | CHURCHILL WINSTON J | Director | Option Exercise | P | 5.84 | 16,832 | 98,299 | 16,832 | |
Jul 05 2005 | AUXL | AUXILIUM PHARMACEU ... | CHURCHILL WINSTON J | Director | Sell | P | 4.90 | 285,641 | 1,399,641 | 514,774 | 800.4 K to 514.8 K (-35.69 %) |
Jul 05 2005 | AUXL | AUXILIUM PHARMACEU ... | CHURCHILL WINSTON J | Director | Sell | P | 4.90 | 661,056 | 3,239,174 | 3,687,878 | 4.3 M to 3.7 M (-15.20 %) |
Jul 05 2005 | AUXL | AUXILIUM PHARMACEU ... | CHURCHILL WINSTON J | Director | Sell | P | 4.90 | 67,330 | 329,917 | 67,330 | 134.7 K to 67.3 K (-50.00 %) |
Jul 05 2005 | AUXL | AUXILIUM PHARMACEU ... | PERSEUS SOROS BIOPHARMACEUTICA ... | 10% Owner | Option Exercise | P | 5.84 | 153,022 | 893,648 | 153,022 | |
Jul 05 2005 | AUXL | AUXILIUM PHARMACEU ... | PERSEUS SOROS BIOPHARMACEUTICA ... | 10% Owner | Buy | P | 4.90 | 612,089 | 2,999,236 | 3,877,403 | 3.3 M to 3.9 M (+18.75 %) |
Jul 05 2005 | AUXL | AUXILIUM PHARMACEU ... | CREDIT SUISSE/ | 10% Owner | Option Exercise | P | 5.84 | 301,453 | 1,760,486 | 932,483 | |
Jul 05 2005 | AUXL | AUXILIUM PHARMACEU ... | CREDIT SUISSE/ | 10% Owner | Buy | P | 4.90 | 1,205,815 | 5,908,494 | 3,508,047 | 2.3 M to 3.5 M (+52.38 %) |
Jun 07 2005 | AUXL | AUXILIUM PHARMACEU ... | Mattila Jyrki | Executive Vice Pres ... | Option Exercise | A | 5.36 | 105,000 | 562,800 | 105,000 | |
May 20 2005 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Option Exercise | A | 4.78 | 100,000 | 478,000 | 100,000 | |
May 20 2005 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Grant | A | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
Mar 22 2005 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Option Exercise | A | 5.36 | 110,000 | 589,600 | 110,000 | |
Aug 02 2004 | AUXL | AUXILIUM PHARMACEU ... | CREDIT SUISSE FIRST BOSTON/ | 10% Owner | Option Exercise | C | 5.63 | 640,639 | 3,603,594 | 640,639 | |
Aug 02 2004 | AUXL | AUXILIUM PHARMACEU ... | CREDIT SUISSE FIRST BOSTON/ | 10% Owner | Buy | P | 7.50 | 200,000 | 1,500,000 | 2,333,332 | 2.1 M to 2.3 M (+9.38 %) |
Aug 02 2004 | AUXL | AUXILIUM PHARMACEU ... | CREDIT SUISSE FIRST BOSTON/ | 10% Owner | Buy | C | 7.50 | 2,133,332 | 15,999,990 | 2,333,332 | 200 K to 2.3 M (+1,066.67 %) |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CHURCHILL WINSTON J | Director | Option Exercise | X | 0.00 | 80,000 | 0 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CHURCHILL WINSTON J | Director | Option Exercise | X | 1.25 | 80,000 | 100,000 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CHURCHILL WINSTON J | Director | Option Exercise | C | 5.63 | 10,856 | 61,065 | 10,856 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CHURCHILL WINSTON J | Director | Option Exercise | C | 5.63 | 131,684 | 740,723 | 131,684 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CHURCHILL WINSTON J | Director | Option Exercise | C | 0.00 | 54,281 | 0 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CHURCHILL WINSTON J | Director | Option Exercise | C | 0.00 | 180,759 | 0 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CHURCHILL WINSTON J | Director | Option Exercise | C | 0.00 | 500,000 | 0 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CHURCHILL WINSTON J | Director | Option Exercise | C | 0.00 | 438,596 | 0 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CHURCHILL WINSTON J | Director | Option Exercise | C | 0.00 | 658,424 | 0 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CHURCHILL WINSTON J | Director | Option Exercise | C | 0.00 | 2,192,555 | 0 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CHURCHILL WINSTON J | Director | Option Exercise | C | 0.00 | 2,166,667 | 0 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CHURCHILL WINSTON J | Director | Option Exercise | C | 0.00 | 884,888 | 0 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CHURCHILL WINSTON J | Director | Option Exercise | C | 0.00 | 8,333,332 | 0 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CHURCHILL WINSTON J | Director | Buy | P | 7.50 | 50,000 | 375,000 | 3,042,822 | 3 M to 3 M (+1.67 %) |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CHURCHILL WINSTON J | Director | Buy | C | 0.00 | 223,870 | 0 | 229,133 | 5.3 K to 229.1 K (+4,253.66 %) |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CHURCHILL WINSTON J | Director | Buy | C | 0.00 | 2,731,486 | 0 | 3,042,822 | 311.3 K to 3 M (+877.34 %) |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CHAMBON PHILIPPE | Director | Option Exercise | C | 5.63 | 2,472 | 13,905 | 2,472 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CHAMBON PHILIPPE | Director | Option Exercise | C | 5.63 | 627,244 | 3,528,248 | 627,244 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CHAMBON PHILIPPE | Director | Option Exercise | C | 5.63 | 1,314 | 7,391 | 1,314 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CHAMBON PHILIPPE | Director | Option Exercise | C | 1.13 | 12,360 | 13,905 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CHAMBON PHILIPPE | Director | Option Exercise | C | 1.13 | 3,136,224 | 3,528,252 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CHAMBON PHILIPPE | Director | Option Exercise | C | 1.13 | 6,571 | 7,392 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CHAMBON PHILIPPE | Director | Option Exercise | C | 0.00 | 41,158 | 0 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CHAMBON PHILIPPE | Director | Option Exercise | C | 0.00 | 10,443,625 | 0 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CHAMBON PHILIPPE | Director | Option Exercise | C | 0.00 | 21,883 | 0 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CHAMBON PHILIPPE | Director | Buy | P | 7.50 | 783 | 5,873 | 9,014 | 8.2 K to 9 K (+9.51 %) |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CHAMBON PHILIPPE | Director | Buy | P | 7.50 | 198,800 | 1,491,000 | 2,287,525 | 2.1 M to 2.3 M (+9.52 %) |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CHAMBON PHILIPPE | Director | Buy | P | 7.50 | 417 | 3,128 | 4,793 | 4.4 K to 4.8 K (+9.53 %) |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CHAMBON PHILIPPE | Director | Buy | C | 0.00 | 8,231 | 0 | 9,014 | 783 to 9 K (+1,051.21 %) |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CHAMBON PHILIPPE | Director | Buy | C | 0.00 | 2,088,725 | 0 | 2,287,525 | 198.8 K to 2.3 M (+1,050.67 %) |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CHAMBON PHILIPPE | Director | Buy | C | 0.00 | 4,376 | 0 | 4,793 | 417 to 4.8 K (+1,049.40 %) |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | HENWOOD GERALDINE | Chief Executive Off ... | Buy | P | 7.50 | 500 | 3,750 | 293,800 | 293.3 K to 293.8 K (+0.17 %) |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | Lansing Cornelius H II | CFO and Executive V ... | Buy | P | 7.50 | 500 | 3,750 | 4,500 | 4 K to 4.5 K (+12.50 %) |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | WHITEHEAD ROBERT S | President and COO | Buy | P | 7.50 | 500 | 3,750 | 500 | 0 to 500 |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | SCP PRIVATE EQUITY PARTNERS II ... | 10% Owner | Option Exercise | X | 0.00 | 80,000 | 0 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | SCP PRIVATE EQUITY PARTNERS II ... | 10% Owner | Option Exercise | X | 1.25 | 80,000 | 100,000 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | SCP PRIVATE EQUITY PARTNERS II ... | 10% Owner | Option Exercise | C | 5.63 | 131,684 | 740,723 | 131,684 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | SCP PRIVATE EQUITY PARTNERS II ... | 10% Owner | Option Exercise | C | 0.00 | 658,424 | 0 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | SCP PRIVATE EQUITY PARTNERS II ... | 10% Owner | Option Exercise | C | 0.00 | 2,192,555 | 0 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | SCP PRIVATE EQUITY PARTNERS II ... | 10% Owner | Option Exercise | C | 0.00 | 2,166,667 | 0 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | SCP PRIVATE EQUITY PARTNERS II ... | 10% Owner | Option Exercise | C | 0.00 | 884,888 | 0 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | SCP PRIVATE EQUITY PARTNERS II ... | 10% Owner | Option Exercise | C | 0.00 | 8,333,332 | 0 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | SCP PRIVATE EQUITY PARTNERS II ... | 10% Owner | Buy | C | 0.00 | 2,731,486 | 0 | 3,042,822 | 311.3 K to 3 M (+877.34 %) |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | SCP PRIVATE EQUITY PARTNERS II ... | 10% Owner | Buy | P | 7.50 | 50,000 | 375,000 | 311,336 | 261.3 K to 311.3 K (+19.13 %) |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CIP CAPITAL LP | 10% Owner | Option Exercise | C | 5.63 | 10,856 | 61,065 | 10,856 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CIP CAPITAL LP | 10% Owner | Option Exercise | C | 0.00 | 54,281 | 0 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CIP CAPITAL LP | 10% Owner | Option Exercise | C | 0.00 | 180,759 | 0 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CIP CAPITAL LP | 10% Owner | Option Exercise | C | 0.00 | 500,000 | 0 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CIP CAPITAL LP | 10% Owner | Option Exercise | C | 0.00 | 438,596 | 0 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | CIP CAPITAL LP | 10% Owner | Buy | C | 0.00 | 223,870 | 0 | 229,133 | 5.3 K to 229.1 K (+4,253.66 %) |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | SOROS FUND MANAGEMENT LLC | 10% Owner | Option Exercise | C | 0.00 | 2,529,729 | 0 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | SOROS FUND MANAGEMENT LLC | 10% Owner | Option Exercise | C | 0.00 | 2,733,334 | 0 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | SOROS FUND MANAGEMENT LLC | 10% Owner | Option Exercise | C | 0.00 | 10,400,000 | 0 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | SOROS FUND MANAGEMENT LLC | 10% Owner | Buy | P | 7.50 | 50,000 | 375,000 | 3,265,314 | 3.2 M to 3.3 M (+1.56 %) |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | SOROS FUND MANAGEMENT LLC | 10% Owner | Buy | C | 0.00 | 505,855 | 0 | 3,215,314 | 2.7 M to 3.2 M (+18.67 %) |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | SOROS FUND MANAGEMENT LLC | 10% Owner | Buy | C | 0.00 | 546,666 | 0 | 2,709,459 | 2.2 M to 2.7 M (+25.28 %) |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | SOROS FUND MANAGEMENT LLC | 10% Owner | Buy | C | 0.00 | 2,080,000 | 0 | 2,162,793 | 82.8 K to 2.2 M (+2,512.29 %) |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | PERSEUS SOROS BIOPHARMACEUTICA ... | 10% Owner | Option Exercise | C | 0.00 | 2,529,729 | 0 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | PERSEUS SOROS BIOPHARMACEUTICA ... | 10% Owner | Option Exercise | C | 0.00 | 2,733,334 | 0 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | PERSEUS SOROS BIOPHARMACEUTICA ... | 10% Owner | Option Exercise | C | 0.00 | 10,400,000 | 0 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | PERSEUS SOROS BIOPHARMACEUTICA ... | 10% Owner | Buy | P | 7.50 | 50,000 | 375,000 | 3,265,314 | 3.2 M to 3.3 M (+1.56 %) |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | PERSEUS SOROS BIOPHARMACEUTICA ... | 10% Owner | Buy | C | 0.00 | 505,855 | 0 | 3,215,314 | 2.7 M to 3.2 M (+18.67 %) |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | PERSEUS SOROS BIOPHARMACEUTICA ... | 10% Owner | Buy | C | 0.00 | 546,666 | 0 | 2,709,459 | 2.2 M to 2.7 M (+25.28 %) |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | PERSEUS SOROS BIOPHARMACEUTICA ... | 10% Owner | Buy | C | 0.00 | 2,080,000 | 0 | 2,162,793 | 82.8 K to 2.2 M (+2,512.29 %) |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | PEARL FRANK H | 10% Owner | Option Exercise | C | 0.00 | 2,529,729 | 0 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | PEARL FRANK H | 10% Owner | Option Exercise | C | 0.00 | 2,733,334 | 0 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | PEARL FRANK H | 10% Owner | Option Exercise | C | 0.00 | 10,400,000 | 0 | 0 | |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | PEARL FRANK H | 10% Owner | Buy | P | 7.50 | 50,000 | 375,000 | 3,265,314 | 3.2 M to 3.3 M (+1.56 %) |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | PEARL FRANK H | 10% Owner | Buy | C | 0.00 | 505,855 | 0 | 3,215,314 | 2.7 M to 3.2 M (+18.67 %) |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | PEARL FRANK H | 10% Owner | Buy | C | 0.00 | 546,666 | 0 | 2,709,459 | 2.2 M to 2.7 M (+25.28 %) |
Jul 30 2004 | AUXL | AUXILIUM PHARMACEU ... | PEARL FRANK H | 10% Owner | Buy | C | 0.00 | 2,080,000 | 0 | 2,162,793 | 82.8 K to 2.2 M (+2,512.29 %) |
Jul 27 2004 | AUXL | AUXILIUM PHARMACEU ... | Purcell Dennis J | Director | Option Exercise | A | 7.50 | 10,000 | 75,000 | 10,000 | |
Jul 27 2004 | AUXL | AUXILIUM PHARMACEU ... | CHAMBON PHILIPPE | Director | Option Exercise | A | 7.50 | 10,000 | 75,000 | 10,000 | |
Jul 27 2004 | AUXL | AUXILIUM PHARMACEU ... | WHITEHEAD ROBERT S | President and COO | Option Exercise | A | 7.50 | 300,000 | 2,250,000 | 300,000 | |
Jul 27 2004 | AUXL | AUXILIUM PHARMACEU ... | WALL MICHAEL A | Director | Option Exercise | A | 7.50 | 10,000 | 75,000 | 10,000 | |
Jul 27 2004 | AUXL | AUXILIUM PHARMACEU ... | Sebree Terri B | Senior Vice Preside ... | Option Exercise | A | 7.50 | 26,640 | 199,800 | 26,640 | |
Jul 27 2004 | AUXL | AUXILIUM PHARMACEU ... | Sebree Terri B | Senior Vice Preside ... | Grant | A | 0.00 | 5,920 | 0 | 37,920 | 32 K to 37.9 K (+18.50 %) |
Jul 27 2004 | AUXL | AUXILIUM PHARMACEU ... | Mattila Jyrki | Executive Vice Pres ... | Option Exercise | A | 7.50 | 51,840 | 388,800 | 51,840 | |
Jul 27 2004 | AUXL | AUXILIUM PHARMACEU ... | Mattila Jyrki | Executive Vice Pres ... | Grant | A | 0.00 | 11,520 | 0 | 11,520 | 0 to 11.5 K |
Jul 27 2004 | AUXL | AUXILIUM PHARMACEU ... | Lansing Cornelius H II | CFO and Executive V ... | Option Exercise | A | 7.50 | 18,000 | 135,000 | 18,000 | |
Jul 27 2004 | AUXL | AUXILIUM PHARMACEU ... | Lansing Cornelius H II | CFO and Executive V ... | Grant | A | 0.00 | 4,000 | 0 | 4,000 | 0 to 4 K |
Jul 27 2004 | AUXL | AUXILIUM PHARMACEU ... | Hollingsworth Jane H | Executive VP & Gene ... | Option Exercise | A | 7.50 | 12,000 | 90,000 | 12,000 | |
Jul 27 2004 | AUXL | AUXILIUM PHARMACEU ... | Hollingsworth Jane H | Executive VP & Gene ... | Grant | A | 0.00 | 2,666 | 0 | 103,166 | 100.5 K to 103.2 K (+2.65 %) |
Jul 27 2004 | AUXL | AUXILIUM PHARMACEU ... | HENWOOD GERALDINE | Chief Executive Off ... | Option Exercise | A | 7.50 | 80,000 | 600,000 | 80,000 | |
Jul 27 2004 | AUXL | AUXILIUM PHARMACEU ... | HENWOOD GERALDINE | Chief Executive Off ... | Grant | A | 0.00 | 60,000 | 0 | 293,300 | 233.3 K to 293.3 K (+25.72 %) |
Jul 27 2004 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Option Exercise | A | 7.50 | 10,000 | 75,000 | 10,000 | |
Jul 27 2004 | AUXL | AUXILIUM PHARMACEU ... | CHURCHILL WINSTON J | Director | Option Exercise | A | 7.50 | 10,000 | 75,000 | 10,000 | |
Jul 27 2004 | AUXL | AUXILIUM PHARMACEU ... | CHURCHILL WINSTON J | Director | Option Exercise | A | 7.50 | 10,000 | 75,000 | 10,000 | |
Jul 27 2004 | AUXL | AUXILIUM PHARMACEU ... | Bescherer Edwin A Jr | Director | Option Exercise | A | 7.50 | 10,000 | 75,000 | 10,000 | |
Jul 27 2004 | AUXL | AUXILIUM PHARMACEU ... | PEARL FRANK H | 10% Owner | Option Exercise | J | 7.50 | 10,000 | 75,000 | 10,000 | |
Jul 27 2004 | AUXL | AUXILIUM PHARMACEU ... | SOROS FUND MANAGEMENT LLC | 10% Owner | Option Exercise | J | 7.50 | 10,000 | 75,000 | 10,000 |